Evidence map›Paper›PMID 25187637›Full record

ArticleJournal of clinical microbiology2014

Characterization and multicentric validation of a common standard for Toxoplasma gondii detection using nucleic acid amplification assays.

Emmanuelle Varlet-Marie, Yvon Sterkers, Marie-Pierre Brenier-Pinchart, Sophie Cassaing, Frédéric Dalle, Laurence Delhaes, Denis Filisetti, Hervé Pelloux, Fériel Touafek, Hélène Yera and 1 more

Abstract readMulticenter StudyValidation Study
In one paragraph

Article in Journal of clinical microbiology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Article
  3. New evaluation of the Toxoplasma ELITe MGB assay on the ELITe Ingenius™ platform (ELITechGroup).European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2025
    Article
  4. Multicenter evaluation of theJournal of clinical microbiology · 2024
    Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Emmanuelle Varlet-MarieCHU (University Hospital Centre) of Montpellier/University Montpellier I, Laboratoire de Parasitologie-Mycologie, Montpellier, France Pôle Biologie Moléculaire du Centre National de Référence de la Toxoplasmose, Montpellier, France University Montpellier I, Faculty of Pharmacy, Laboratoire de Biophysique & Bioanalyse, Montpellier, France.
Yvon SterkersCHU (University Hospital Centre) of Montpellier/University Montpellier I, Laboratoire de Parasitologie-Mycologie, Montpellier, France Pôle Biologie Moléculaire du Centre National de Référence de la Toxoplasmose, Montpellier, France.
Marie-Pierre Brenier-PinchartPôle Biologie Moléculaire du Centre National de Référence de la Toxoplasmose, Montpellier, France CHU A. Michallon/University Joseph Fourier Grenoble I, Laboratoire de Parasitologie-Mycologie, Département des Agents Infectieux, Grenoble, France.
Sophie CassaingPôle Biologie Moléculaire du Centre National de Référence de la Toxoplasmose, Montpellier, France CHU of Toulouse, Service de Parasitologie-Mycologie, Toulouse, France.
Frédéric DallePôle Biologie Moléculaire du Centre National de Référence de la Toxoplasmose, Montpellier, France CHU of Dijon, Laboratoire de Parasitologie-Mycologie, Faculty of Medicine, Université de Bourgogne, UMR 1347 Aggroécologie, Dijon, France.
Laurence DelhaesPôle Biologie Moléculaire du Centre National de Référence de la Toxoplasmose, Montpellier, France CHU of Lille/Université Nord de France (UDSL), Service de Parasitologie-Mycologie, Faculty of Medicine, Institut Pasteur de Lille, Lille, France.
Denis FilisettiPôle Biologie Moléculaire du Centre National de Référence de la Toxoplasmose, Montpellier, France Hôpitaux Universitaires de Strasbourg/University of Strasbourg, Laboratoire de Parasitologie et Mycologie Médicales, Strasbourg, France.
Hervé PellouxPôle Biologie Moléculaire du Centre National de Référence de la Toxoplasmose, Montpellier, France CHU A. Michallon/University Joseph Fourier Grenoble I, Laboratoire de Parasitologie-Mycologie, Département des Agents Infectieux, Grenoble, France.
Fériel TouafekPôle Biologie Moléculaire du Centre National de Référence de la Toxoplasmose, Montpellier, France AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Laboratoire de Parasitologie-Mycologie, Paris, France.
Hélène YeraPôle Biologie Moléculaire du Centre National de Référence de la Toxoplasmose, Montpellier, France University Paris Descartes, AP-HP, Groupe Hospitalier Cochin, Laboratoire de Parasitologie-Mycologie, Paris, France.
Patrick BastienCHU (University Hospital Centre) of Montpellier/University Montpellier I, Laboratoire de Parasitologie-Mycologie, Montpellier, France Pôle Biologie Moléculaire du Centre National de Référence de la Toxoplasmose, Montpellier, France p-bastien@chu-montpellier.fr.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The molecular diagnosis of toxoplasmosis essentially relies upon laboratory-developed methods and suffers from lack of standardization, hence the large diversity of performances between laboratories. Moreover, quantifications of parasitic loads differ among centers, a fact which prevents the possible prediction of the severity of this disease as a function of parasitic loads. The objectives of this multicentric study performed in eight proficient laboratories of the Molecular Biology Pole of the French National Reference Center for Toxoplasmosis (NRC-T) were (i) to assess the suitability of a lyophilized preparation of Toxoplasma gondii as a common standard for use in this PCR-based molecular diagnosis and (ii) to make this standard available to the community. High-quality written procedures were used for the production and qualification of this standard. Three independent batches of this standard, containing concentrations ranging from 10(4) to 0.01 T. gondii genome equivalents per PCR, were first assessed: the linear dynamic range was ≥ 6 log, the intra-assay coefficients of variation (CV) from a sample containing 10 T. gondii organisms per PCR were 0.3% to 0.42%, and the interassay CV over a 2-week period was 0.76% to 1.47%. A further assessment in eight diagnostic centers showed that the standard is stable, robust, and reliable. These lyophilized standards can easily be produced at a larger scale when needed and can be made widely available at the national level. To our knowledge, this is the first quality control assessment of a common standard which is usable both for self-evaluation in laboratories and for accurate quantification of parasitic loads in T. gondii prenatal infections.

Indexed as

Reference StandardsFranceHumansMolecular Diagnostic TechniquesNucleic Acid Amplification TechniquesParasite LoadToxoplasmaToxoplasmosis

Identifiers

PMID25187637
PMCPMC4313224

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.